Focused Articles

Please see our separate page on COVID-19

European Journal of Radiology Special Issue on Chest Imaging

Interstitial Lung Abnormality

  • “Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.” Lancet Resp Med 2020
  • “Interstitial Lung Abnormality: Recognition and Perspectives.” Radiology 2018
  • “Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities.” NEJM 2011
  • MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities.” NEJM 2013
  • “Association Between Interstitial Lung Abnormalities and All-Cause Mortality” JAMA 2016
  • “Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study” AJRCCM 2016

Management of Incidental Pulmonary Nodules

  • “Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 Lesions” Academic Radiology 2020
  • “Cost-Effectiveness of Follow-Up for Subsolid Pulmonary Nodules in High-Risk Patients” J Thoracic Oncol 2020
  • “Radiologic-Pathologic Correlation for Nondiagnostic CT-Guided Lung Biopsies Performed for the Evaluation of Lung Cancer” Am J Roentgenol 2020
  • “Cancer Risk in Subsolid Nodules in the National Lung Screening Trial” Radiology 2019
  • “A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules” Radiology 2018
  • “Limited Utility of Pulmonary Nodule Risk Calculators for Managing Large Nodules” Curr Prob Diag Radiol 2018

Lung Disease in Immunocompromised Hosts

  • ” Significance of the Reverse Halo Sign in Immunocompromised Patients” AJR 2019
  • “Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time” AJR 2018
  • “Human Herpesvirus Alpha Subfamily (Herpes Simplex and Varicella Zoster) Viral Pneumonias: CT Findings” JTI 2018

Imaging of Immune Checkpoint Inhibitors Pneumonitis

  • “Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care” Radiographics 2017
  • “Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy” NEJM 2015
  • “Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis” JAMA Oncology 2016
  • “PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course” Clin Cancer Res 2016
  • “Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society.” Radiology 2021

Imaging of Tumor Response

  • “State of the art: Response assessment in lung cancer in the era of genomic medicine” Radiology 2014
  • “Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.” Radiology 2019
  • “Monitoring immune-checkpoint blockade: response evaluation and biomarker development” Nat Rev Clin Oncol 2017
  • “Tumor Response Dynamics of Advanced Non-small Cell Lung Cancer Patients Treated with PD-1 Inhibitors: Imaging Markers for Treatment Outcome” Clin Cancer Res 2017
  • “Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer” JTO 2018

Pulmonary Functional Imaging and MRI of the Lung